Obstructive Sleep Apnea Clinical Trial
— We-PAPOfficial title:
A Novel Couples- Based Sleep Health Intervention For Older Adults With Obstructive Sleep Apnea: Implications for Alzheimer's Disease Risk And Healthy Aging
Verified date | February 2023 |
Source | University of Utah |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to develop, refine and evaluate the feasibility of a novel couples-based intervention to improve adherence for patients with obstructive sleep apnea (OSA).
Status | Completed |
Enrollment | 84 |
Est. completion date | January 31, 2023 |
Est. primary completion date | December 16, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 85 Years |
Eligibility | Inclusion Criteria: Patient and partner inclusion criteria: 1. Age >=50 2. Access to cellular (active data plan) or Wi-Fi, in order to complete the telehealth intervention. Patients inclusion criteria: 1. Diagnosed with OSA (AHI>10 or AHI>5 with impairment) and intend to start PAP treatment 2. PAP naïve or non-use of PAP for at least 3 years 3. Married or cohabiting with a romantic partner for >1 year 4. Able to read/write English. Partner inclusion criteria: 1. Able to read/write English 2. PROMIS sleep disturbance score >55 in either patient or partner, or desire to improve sleep. Exclusion Criteria: Patient only exclusion criteria: 1. Concomitant OSA treatments (bariatric surgery planned in the next 3 months or bariatric surgery in the past year, ear nose and throat surgery for sleep apnea occurring in the 3 months before or planning for within the study period). Exclusion criteria for both patient and partner include the following: 1. High risk or presence of moderate to severe comorbid sleep disorders (i.e., restless legs syndrome) 2. History of cognitive or neurological disorders (e.g., dementia, Parkinson's, Multiple Sclerosis) 3. Presence of major psychiatric disorders (e.g., schizophrenia, bipolar disorder), alcohol abuse reported on the Audit-C (score >4 for men, >3 for women), drug use (NIDA-Modified ASSIST score >3) 4. Unstable or serious medical illness that would interfere with participation (cancer, renal disease on dialysis, moderate to severe COPD) 5. Use of ASV, VPAP or supplemental oxygen 6. Overnight work > 1x per month 7. Pregnancy/ desire to become pregnant in the study period 8. Current participation in behavioral sleep treatment (e.g., CBT-I) or completion of CBT-I in the past 3 years 9. Concurrent participation in another clinical trial 10. Caregiving for an infant < 2 years old or adult who requires overnight assistance. |
Country | Name | City | State |
---|---|---|---|
United States | University of Utah | Salt Lake City | Utah |
Lead Sponsor | Collaborator |
---|---|
University of Utah | National Institute on Aging (NIA), RAND |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Relationship satisfaction | Patient and partner relationship quality will be measured via self-report | 1 and 3 months | |
Other | Cognitive functioning | Patient and partner change in cognitive functioning will be measured using the RBANS instrument | 3 months | |
Primary | Hours of CPAP use | Patient adherence to CPAP will be measured via download of their machine | 3 months | |
Secondary | Self-reported sleep | Patient and partner self-reported sleep quality will be measured using the PROMIS sleep disturbance measure at baseline, 1 and 3 months | 1 and 3 months | |
Secondary | Objective sleep | Patient and partner objective sleep quality will be measured using actigraphy at baseline, 1 and 3 months | 1 month and 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05857384 -
Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
|
Phase 1 | |
Recruiting |
NCT04547543 -
Follow-up of Apneic Patients by Visio-consultation
|
N/A | |
Recruiting |
NCT05371509 -
Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study
|
N/A | |
Completed |
NCT02515357 -
Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT05582070 -
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
|
N/A | |
Active, not recruiting |
NCT03189173 -
Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
|
Phase 2 | |
Completed |
NCT04084899 -
The Effect of CPAP on Lung Hyperinflation in Patients With OSA
|
||
Completed |
NCT03032029 -
Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
|
||
Recruiting |
NCT04028011 -
Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
|
||
Recruiting |
NCT06047353 -
Community Health Advocates for Motivating PAP Use in Our Neighborhoods.
|
N/A | |
Completed |
NCT05253963 -
Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Completed |
NCT03589417 -
Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
|
||
Recruiting |
NCT04335994 -
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
|
N/A | |
Withdrawn |
NCT04063436 -
Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT05385302 -
Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
|
||
Recruiting |
NCT04572269 -
Metabolomics of Obstructive Sleep Apnea
|
||
Not yet recruiting |
NCT06467682 -
12-week Tele-exercise Program in Patients With OSA
|
N/A | |
Withdrawn |
NCT04011358 -
Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study
|
N/A |